%PDF-1.5
%
1 0 obj<>
endobj
2 0 obj<>
endobj
3 0 obj<>
endobj
5 0 obj null
endobj
6 0 obj<>
endobj
7 0 obj<>
endobj
8 0 obj<>>>
endobj
9 0 obj<>
endobj
10 0 obj<><><><><>]/C/SpdrArt/P 9 0 R/S/Article/Pg 11 0 R>>
endobj
11 0 obj<>/ProcSet[/PDF/Text]>>/StructParents 0>>
endobj
12 0 obj<>/Subtype/Link/A<>>>
endobj
13 0 obj<>/Font<>>>/DA(/Helv 0 Tf 0 g )>>
endobj
14 0 obj<>
endobj
15 0 obj<>
endobj
16 0 obj<>
endobj
17 0 obj[12 0 R 20 0 R 21 0 R 22 0 R]
endobj
18 0 obj<>
endobj
19 0 obj[10 0 R]
endobj
20 0 obj<>/Subtype/Link/A<>>>
endobj
21 0 obj<>/Subtype/Link/A<>>>
endobj
22 0 obj<>/Subtype/Link/A<>>>
endobj
23 0 obj<>/ProcSet[/PDF/Text]>>/StructParents 1>>
endobj
24 0 obj[10 0 R 10 0 R]
endobj
25 0 obj<>/ProcSet[/PDF/Text]>>/StructParents 2>>
endobj
26 0 obj[10 0 R 10 0 R]
endobj
27 0 obj<>/Subtype/Link/A<>>>
endobj
28 0 obj[27 0 R]
endobj
29 0 obj<>/ProcSet[/PDF/Text]>>/StructParents 3>>
endobj
30 0 obj[10 0 R]
endobj
31 0 obj<>
endobj
32 0 obj<>
endobj
33 0 obj<>
endobj
34 0 obj<>
endobj
35 0 obj<>
endobj
36 0 obj<>
endobj
37 0 obj<>
endobj
38 0 obj 9336
endobj
39 0 obj<>stream
/Artifact <>BDC
0 0 0 rg
0 i
BT
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 18 780.17 Tm
(HIVInfo.us - Aptivus - tipranavir information)Tj
ET
EMC
/WebCaptureBG BMC
/WebCaptureFN <>BDC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
10 766 m
501.422 766 l
500.422 765 l
11 765 l
h
f
10 766 m
10 694.39999 l
11 695.39999 l
11 765 l
h
f
501.422 766 m
501.422 694.39999 l
500.422 695.39999 l
500.422 765 l
h
f
10 694.39999 m
501.422 694.39999 l
500.422 695.39999 l
11 695.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0 0.50197 0 rg
16 733.2 479.422 26.8 re
f
0 0 0 rg
15 761 m
496.422 761 l
495.422 760 l
16 760 l
h
f
15 761 m
15 732.2 l
16 733.2 l
16 760 l
h
f
496.422 761 m
496.422 732.2 l
495.422 733.2 l
495.422 760 l
h
f
15 732.2 m
496.422 732.2 l
495.422 733.2 l
16 733.2 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
1 1 1 rg
16 700.39999 479.422 26.8 re
f
0 0 0 rg
15 728.2 m
496.422 728.2 l
495.422 727.2 l
16 727.2 l
h
f
15 728.2 m
15 699.39999 l
16 700.39999 l
16 727.2 l
h
f
496.422 728.2 m
496.422 699.39999 l
495.422 700.39999 l
495.422 727.2 l
h
f
15 699.39999 m
496.422 699.39999 l
495.422 700.39999 l
16 700.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0.06667 0.06667 0.06667 rg
10 680.39999 m
602 680.39999 l
599 677.39999 l
13 677.39999 l
h
f
10 680.39999 m
10 36 l
13 36 l
13 677.39999 l
h
f
602 680.39999 m
602 36 l
599 36 l
599 677.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0.50197 0 0.50197 rg
18 643.39999 576 29 re
f
0.06667 0.06667 0.06667 rg
17 673.39999 m
595 673.39999 l
594 672.39999 l
18 672.39999 l
h
f
17 673.39999 m
17 642.39999 l
18 643.39999 l
18 672.39999 l
h
f
595 673.39999 m
595 642.39999 l
594 643.39999 l
594 672.39999 l
h
f
17 642.39999 m
595 642.39999 l
594 643.39999 l
18 643.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 638.39999 m
112.02 638.39999 l
111.02 637.39999 l
18 637.39999 l
h
f
17 638.39999 m
17 595.39999 l
18 596.39999 l
18 637.39999 l
h
f
112.02 638.39999 m
112.02 595.39999 l
111.02 596.39999 l
111.02 637.39999 l
h
f
17 595.39999 m
112.02 595.39999 l
111.02 596.39999 l
18 596.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
116.02 638.39999 m
595 638.39999 l
594 637.39999 l
117.02 637.39999 l
h
f
116.02 638.39999 m
116.02 595.39999 l
117.02 596.39999 l
117.02 637.39999 l
h
f
595 638.39999 m
595 595.39999 l
594 596.39999 l
594 637.39999 l
h
f
116.02 595.39999 m
595 595.39999 l
594 596.39999 l
117.02 596.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 591.39999 m
112.02 591.39999 l
111.02 590.39999 l
18 590.39999 l
h
f
17 591.39999 m
17 499.29231 l
18 500.29231 l
18 590.39999 l
h
f
112.02 591.39999 m
112.02 499.29231 l
111.02 500.29231 l
111.02 590.39999 l
h
f
17 499.29231 m
112.02 499.29231 l
111.02 500.29231 l
18 500.29231 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
116.02 591.39999 m
595 591.39999 l
594 590.39999 l
117.02 590.39999 l
h
f
116.02 591.39999 m
116.02 499.29231 l
117.02 500.29231 l
117.02 590.39999 l
h
f
595 591.39999 m
595 499.29231 l
594 500.29231 l
594 590.39999 l
h
f
116.02 499.29231 m
595 499.29231 l
594 500.29231 l
117.02 500.29231 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 495.29231 m
112.02 495.29231 l
111.02 494.29231 l
18 494.29231 l
h
f
17 495.29231 m
17 357.71938 l
18 358.71938 l
18 494.29231 l
h
f
112.02 495.29231 m
112.02 357.71938 l
111.02 358.71938 l
111.02 494.29231 l
h
f
17 357.71938 m
112.02 357.71938 l
111.02 358.71938 l
18 358.71938 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
116.02 495.29231 m
595 495.29231 l
594 494.29231 l
117.02 494.29231 l
h
f
116.02 495.29231 m
116.02 357.71938 l
117.02 358.71938 l
117.02 494.29231 l
h
f
595 495.29231 m
595 357.71938 l
594 358.71938 l
594 494.29231 l
h
f
116.02 357.71938 m
595 357.71938 l
594 358.71938 l
117.02 358.71938 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 353.71938 m
112.02 353.71938 l
111.02 352.71938 l
18 352.71938 l
h
f
17 353.71938 m
17 36 l
18 36 l
18 352.71938 l
h
f
112.02 353.71938 m
112.02 36 l
111.02 36 l
111.02 352.71938 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
116.02 353.71938 m
595 353.71938 l
594 352.71938 l
117.02 352.71938 l
h
f
116.02 353.71938 m
116.02 36 l
117.02 36 l
117.02 352.71938 l
h
f
595 353.71938 m
595 36 l
594 36 l
594 352.71938 l
h
f
EMC
EMC
EMC
/Article <>BDC
q
0 18 612 756 re
W* n
1 1 1 rg
BT
/TT0 1 Tf
14 0 0 14 20 744.39798 Tm
(HIVInfo.us )Tj
10.76923 0 0 10.76923 93.12199 744.39798 Tm
(presents)Tj
0 0 0 rg
14 0 0 14 20 711.59798 Tm
(An HIV Information Site & HIV Educational Resource Site \(HIS & HERS\))Tj
1 1 1 rg
17.5 0 0 17.5 22 653.89748 Tm
(tipranavir - Aptivus)Tj
0 0 0 rg
13.75 0 0 13.75 38.9075 622.00516 Tm
(General )Tj
-0.888 -1.2 Td
(Information)Tj
/TT1 1 Tf
14 0 0 14 121.02 620.81848 Tm
(T)Tj
12.5 0 0 12.5 129.57401 620.81848 Tm
(ipranavir \(Aptivus\) is almost always used as one component of a multid\
rug )Tj
-0.68433 -1.2413 Td
(combination to suppress the human immunodeficiency \(HIV\) viral load.)Tj
/TT0 1 Tf
13.75 0 0 13.75 34.32187 542.20131 Tm
(Specifics)Tj
/TT1 1 Tf
12.92308 0 0 12.92308 121.02 575.34013 Tm
(Tipranavir is one of the most potent antiviral drugs against HIV infecti\
on. )Tj
0 -1.26631 TD
(Tipranavir is always combined with another protease inhibitor called rit\
onavir.)Tj
/T1_0 1 Tf
14 0 0 14 561.27046 558.97556 Tm
( )Tj
/TT1 1 Tf
12.92308 0 0 12.92308 121.02 524.24783 Tm
(Tipranavir works by inhibiting the production of HIV's proteins. Tipran\
avir is )Tj
0 -1.2 TD
(classified as a protease inhibitor \(PI\) combination.)Tj
/TT0 1 Tf
13.75 0 0 13.75 41.21063 423.36101 Tm
(Dosing)Tj
/TT1 1 Tf
12.92308 0 0 12.92308 121.02 479.23245 Tm
(Generally tipranavir is taken as two \(2\) 250 mg capsules twice a day w\
ith two \(2\) )Tj
T*
(100 mg ritonavir \(Norvir\) gel caps. Tipranavir and ritonavir are alwa\
ys taken with )Tj
T*
(food. It is very important to take tipranavir with food to prevent it f\
rom irritating )Tj
T*
(your stomach and bowels. )Tj
0 -2.67024 TD
(Tipranavir gel caps )Tj
/TT2 1 Tf
(may)Tj
/TT1 1 Tf
( need to be refrigerated for best results if the ambient )Tj
0 -1.20148 TD
(temperature in your residence exceeds 86 deg Fahrenheit. Keep the bottl\
e in the )Tj
0 -1.2 TD
(refrigerator prior to opening the bottle.)Tj
/TT0 1 Tf
14 0 0 14 22 317.67137 Tm
(Adherence)Tj
18.75 0 0 18.75 94.35201 317.67137 Tm
( )Tj
/TT1 1 Tf
12.5 0 0 12.5 22 300.48701 Tm
(\(this refers to )Tj
T*
(your )Tj
T*
(willingness, )Tj
T*
(ability, and )Tj
T*
(actual )Tj
T*
(performance )Tj
T*
(in taking your )Tj
T*
(medications\))Tj
12.92308 0 0 12.92308 22 161.12492 Tm
(For further )Tj
T*
(information )Tj
T*
(and tips on )Tj
T*
(adherence, )Tj
T*
(go to the )Tj
0.50197 0 0.50197 rg
/TT0 1 Tf
0 -1.1729 TD
(Adherence )Tj
0 -1.38187 TD
(section)Tj
0 0 0 rg
/TT1 1 Tf
( of )Tj
T*
(this site.)Tj
/TT0 1 Tf
7.66226 22.42415 Td
(The "all or none" rule applies to all antiviral medications such as tipr\
anavir: )Tj
0 -1.2 TD
(you should commit yourself to taking every dose, every day OR take none \
)Tj
T*
(at all. Missing doses leads to a worsening of HIV infections \(resistan\
ce to )Tj
0 -1.29341 TD
(medications\) and makes finding a good antiviral medication harder to do\
.)Tj
/T1_0 1 Tf
14 0 0 14 571.28584 290.27956 Tm
( )Tj
/TT0 1 Tf
12.5 0 0 12.5 121.02 255.78363 Tm
(As with any antiviral drug or antibiotic, try not to ever miss a dose.)Tj
/TT1 1 Tf
( If you miss )Tj
0 -1.22711 TD
(a dose and notice that you have done so within a few hours of its schedu\
led time, )Tj
0 -1.2 TD
(you may take the dose as usual and take the next dose at its regular tim\
e. )Tj
12.92308 0 0 12.92308 121.02 191.08272 Tm
(You should never change the dose of tipranavir without speaking to your \
)Tj
T*
(healthcare provider first.)Tj
/TT0 1 Tf
12.5 0 0 12.5 121.02 141.76825 Tm
(If you miss more than one dose, look at the reasons why you missed them \
)Tj
0 -1.22711 TD
(and come up with a plan to avoid it in the future.)Tj
/TT1 1 Tf
( For example, if you fell asleep )Tj
0 -1.2271 TD
(too early, take the medicine earlier in the evening, with your later mea\
l, set an )Tj
0 -1.2 TD
(alarm, or have someone appointed to wake you up for your medicine. )Tj
0 -2.72 TD
(It is strongly recommended that you consider using weekly pill boxes and\
arrange )Tj
0 -1.2 TD
(all of your doses a week in advance. Buy a small pill box so that you c\
an carry a )Tj
ET
EMC
/Artifact <>BDC
Q
0 0 0 rg
BT
/T1_0 1 Tf
9 0 0 9 18 7.17 Tm
(http://www.hivinfo.us/tipranavir.html \(1 of 4\)7/24/2005 7:55:46 AM)Tj
ET
EMC
endstream
endobj
40 0 obj 6312
endobj
41 0 obj<>stream
/Artifact <>BDC
0 0 0 rg
0 i
BT
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 18 780.17 Tm
(HIVInfo.us - Aptivus - tipranavir information)Tj
ET
EMC
/WebCaptureBG BMC
/WebCaptureFN <>BDC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0.06667 0.06667 0.06667 rg
10 766 m
10 36 l
13 36 l
13 766 l
h
f
602 766 m
602 36 l
599 36 l
599 766 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
116.02 766 m
116.02 746 l
117.02 747 l
117.02 766 l
h
f
595 766 m
595 746 l
594 747 l
594 766 l
h
f
116.02 746 m
595 746 l
594 747 l
117.02 747 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 766 m
17 746 l
18 747 l
18 766 l
h
f
112.02 766 m
112.02 746 l
111.02 747 l
111.02 766 l
h
f
17 746 m
112.02 746 l
111.02 747 l
18 747 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 742 m
112.02 742 l
111.02 741 l
18 741 l
h
f
17 742 m
17 336.45384 l
18 337.45384 l
18 741 l
h
f
112.02 742 m
112.02 336.45384 l
111.02 337.45384 l
111.02 741 l
h
f
17 336.45384 m
112.02 336.45384 l
111.02 337.45384 l
18 337.45384 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
116.02 742 m
595 742 l
594 741 l
117.02 741 l
h
f
116.02 742 m
116.02 336.45384 l
117.02 337.45384 l
117.02 741 l
h
f
595 742 m
595 336.45384 l
594 337.45384 l
594 741 l
h
f
116.02 336.45384 m
595 336.45384 l
594 337.45384 l
117.02 337.45384 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 332.45384 m
112.02 332.45384 l
111.02 331.45384 l
18 331.45384 l
h
f
17 332.45384 m
17 36 l
18 36 l
18 331.45384 l
h
f
112.02 332.45384 m
112.02 36 l
111.02 36 l
111.02 331.45384 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
116.02 332.45384 m
595 332.45384 l
594 331.45384 l
117.02 331.45384 l
h
f
116.02 332.45384 m
116.02 36 l
117.02 36 l
117.02 331.45384 l
h
f
595 332.45384 m
595 36 l
594 36 l
594 331.45384 l
h
f
EMC
EMC
EMC
/Article <>BDC
q
0 18 612 756 re
W* n
0 0 0 rg
BT
/TT0 1 Tf
12.5 0 0 12.5 121.02 755.30222 Tm
(dose or two of your medicines with you in case you are away from home.)Tj
/TT1 1 Tf
15 0 0 15 22 708.87311 Tm
(Possible )Tj
0 -1.2 TD
(Side )Tj
T*
(Effects)Tj
/TT0 1 Tf
12.92308 0 0 12.92308 22 656.24399 Tm
(The package )Tj
T*
(insert for )Tj
T*
(most drugs )Tj
T*
(including )Tj
T*
(tipranavir is )Tj
T*
(often )Tj
T*
(overwhelming )Tj
T*
(and scary )Tj
T*
(with perhaps )Tj
T*
(an )Tj
T*
(overemphasis )Tj
T*
(on side )Tj
T*
(effects. We )Tj
T*
(have )Tj
T*
(summarized )Tj
T*
(the important )Tj
0 -1.2 TD
(and more )Tj
0 -1.2 TD
(common )Tj
T*
(problems )Tj
T*
(here.)Tj
/TT1 1 Tf
12.5 0 0 12.5 121.02 726.64105 Tm
(Persons with sulfonamide or sulfa drug allergies should take tipranavir \
)Tj
T*
(cautiously as tipranavir contains a sulfa molecule.)Tj
0 -2.22804 TD
(Many people take )Tj
12.92308 0 0 12.92308 228.69501 683.79044 Tm
(tipranavir )Tj
12.5 0 0 12.5 291.17807 683.79044 Tm
(without many side effects. )Tj
/TT0 1 Tf
-13.61266 -2.75967 Td
(Possible side effects include rash, stomach upset, diarrhea, nausea, liv\
er problems, )Tj
0 -1.2 TD
(increased fat \(cholesterol and triglycerides\) in the blood, turning ye\
llow with )Tj
T*
(jaundice, numbness of the lips or mouth, and possibly diabetes.)Tj
12.92308 0 0 12.92308 121.02 584.93245 Tm
(Persons with chronic hepatitis B or C or other liver problems should hav\
e their )Tj
T*
(liver tests monitored closely.)Tj
12.5 0 0 12.5 121.02 535.27914 Tm
(Usually you will have blood tests done in the first month to look for th\
e beneficial )Tj
T*
(effects of tipranavir and any side effects. )Tj
12.92308 0 0 12.92308 121.02 485.91705 Tm
(Many minor side effects will either stay constant or get better with tim\
e. It is )Tj
T*
(mainly the side effects that are severe or get worse that may cause sign\
ificant )Tj
T*
(health risks for you.)Tj
12.5 0 0 12.5 121.02 420.75606 Tm
(All drugs of this type can cause or contribute to abnormal fat redistrib\
ution )Tj
T*
(characterized by an enlarged belly, a lump on the back of the neck \("bu\
ffalo hump"\), )Tj
T*
(thinning of the face, arms, or legs. In most cases this would be also a\
ccompanied )Tj
T*
(by elevated cholesterol levels, elevated triglyceride levels, and perhap\
s a tendency )Tj
T*
(to develop diabetes. The first symptoms of diabetes are increased thirs\
t and )Tj
T*
(increased urination.)Tj
ET
EMC
/Article <>BDC
BT
/TT0 1 Tf
12.92308 0 0 12.92308 121.02 316.39398 Tm
(Make sure that you tell your healthcare provider about all of your medic\
ations )Tj
T*
(including over-the-counter ones. )Tj
1 0 0 rg
/TT1 1 Tf
0 -2.64313 TD
(Some medications probably should )Tj
0 0 0 rg
(NOT)Tj
1 0 0 rg
( be taken at all with tipranavir:)Tj
0 0 0 rg
0 -2.22711 TD
(Protease inhibitors:)Tj
/TT0 1 Tf
( all other protease inhibitors SHOULD NOT be )Tj
0 -1.2271 TD
(administered with tipranavir)Tj
/TT1 1 Tf
0 -1.2 TD
(Certain antihistamines:)Tj
/TT0 1 Tf
( terfenadine \(Seldane\), astemizole \(Hismanal\))Tj
/TT1 1 Tf
0 -1.22711 TD
(Drugs to increase esophagus and stomach movement:)Tj
/TT0 1 Tf
( cisapride)Tj
/TT1 1 Tf
T*
(Drugs to regulate heart rhythm:)Tj
/TT0 1 Tf
( flecainide \(Tambocor\), propafenone )Tj
0 -1.2271 TD
(\(Rhythmol, Rhythmol SR\), amiodarone, quinidine, bepridil)Tj
/TT1 1 Tf
0 -1.2 TD
(Ergot derivatives for migraine headaches:)Tj
/TT0 1 Tf
( dihydroergotamine \(D.H.E. 45\), )Tj
0 -1.22711 TD
(ergonovine, ergotamine, methylergonovine \(Methergine\))Tj
/TT1 1 Tf
0 -1.2 TD
(Drugs to treat mental health problems \(Tourette's syndrome\):)Tj
/TT0 1 Tf
( pimozide )Tj
0 -1.22711 TD
(\(Orap\))Tj
/TT1 1 Tf
0 -1.2 TD
(Sedatives/sleeping pills:)Tj
/TT0 1 Tf
( midazolam \(Versed\), triazolam \(Halcion\))Tj
/TT1 1 Tf
0 -1.2 TD
(All statins \(drugs to decrease cholesterol\) other than atorvastatin \(\
Lipitor\), )Tj
T*
(pravastatin \(Pravachol\))Tj
ET
EMC
/Artifact <>BDC
Q
0 0 0 rg
BT
/T1_0 1 Tf
9 0 0 9 18 7.17 Tm
(http://www.hivinfo.us/tipranavir.html \(2 of 4\)7/24/2005 7:55:46 AM)Tj
ET
EMC
endstream
endobj
42 0 obj 6206
endobj
43 0 obj<>stream
/Artifact <>BDC
0 0 0 rg
0 i
BT
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 18 780.17 Tm
(HIVInfo.us - Aptivus - tipranavir information)Tj
ET
EMC
/WebCaptureBG BMC
/WebCaptureFN <>BDC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0.06667 0.06667 0.06667 rg
10 766 m
10 42.50328 l
13 45.50328 l
13 766 l
h
f
602 766 m
602 42.50328 l
599 45.50328 l
599 766 l
h
f
10 42.50328 m
602 42.50328 l
599 45.50328 l
13 45.50328 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 766 m
17 158.76788 l
18 159.76788 l
18 766 l
h
f
112.02 766 m
112.02 158.76788 l
111.02 159.76788 l
111.02 766 l
h
f
17 158.76788 m
112.02 158.76788 l
111.02 159.76788 l
18 159.76788 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
116.02 766 m
116.02 158.76788 l
117.02 159.76788 l
117.02 766 l
h
f
595 766 m
595 158.76788 l
594 159.76788 l
594 766 l
h
f
116.02 158.76788 m
595 158.76788 l
594 159.76788 l
117.02 159.76788 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 154.76788 m
595 154.76788 l
594 153.76788 l
18 153.76788 l
h
f
17 154.76788 m
17 81.36128 l
18 82.36128 l
18 153.76788 l
h
f
595 154.76788 m
595 81.36128 l
594 82.36128 l
594 153.76788 l
h
f
17 81.36128 m
595 81.36128 l
594 82.36128 l
18 82.36128 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 77.36128 m
595 77.36128 l
594 76.36128 l
18 76.36128 l
h
f
17 77.36128 m
17 49.50328 l
18 50.50328 l
18 76.36128 l
h
f
595 77.36128 m
595 49.50328 l
594 50.50328 l
594 76.36128 l
h
f
17 49.50328 m
595 49.50328 l
594 50.50328 l
18 50.50328 l
h
f
EMC
EMC
EMC
/Article <>BDC
q
0 18 612 756 re
W* n
0 0 0 rg
BT
/TT0 1 Tf
15 0 0 15 22 689.19637 Tm
(Interactions)Tj
/TT1 1 Tf
12.92308 0 0 12.92308 22 672.56725 Tm
(This refers to )Tj
0 -1.2 TD
(the way that )Tj
T*
(tipranavir )Tj
T*
(affects other )Tj
T*
(medications )Tj
T*
(and how )Tj
T*
(other )Tj
T*
(medications )Tj
T*
(affect )Tj
T*
(tipranavir.)Tj
ET
EMC
/Article <>BDC
BT
/TT0 1 Tf
12.92308 0 0 12.92308 121.02 754.94014 Tm
(Natural remedies:)Tj
/TT1 1 Tf
( St John's wort, garlic capsules)Tj
/TT0 1 Tf
0 -1.22711 TD
(Tuberculosis treatment:)Tj
/TT1 1 Tf
( rifampin \(Rifadin, Rimactane, Rifamate\))Tj
/TT0 1 Tf
0 -2.67023 TD
(Certain drugs should probably be used only very cautiously:)Tj
0 -2.69736 TD
(Antacids that contain aluminum and/or magnesium:)Tj
/TT1 1 Tf
( Maalox, Mylanta, and )Tj
0 -1.2271 TD
(many others - always stagger \(separate\) dose away from tipranavir/rito\
navir by at )Tj
0 -1.20001 TD
(least 2 hours)Tj
/TT0 1 Tf
0 -1.2 TD
(Oral diabetic medicines [hypoglycemics]:)Tj
/TT1 1 Tf
( glimepiride, glipizide, glyburide, )Tj
0 -1.22711 TD
(pioglitazone, repaglinide, tolbutamide - the interaction is unknown and \
therefore )Tj
0 -1.2 TD
(monitor for effectiveness carefully)Tj
/TT0 1 Tf
T*
(Calcium channel blockers:)Tj
/TT1 1 Tf
( diltiazem, felodipine, nicardipine, nisoldipine, )Tj
0 -1.22711 TD
(verapamil)Tj
/TT0 1 Tf
0 -1.2 TD
(Antidepressant:)Tj
/TT1 1 Tf
( desipramine [monitor the blood level and decrease the dose of )Tj
0 -1.2271 TD
(desipramine], fluoxetine, paroxetine, sertraline)Tj
/TT0 1 Tf
0 -1.2 TD
(Certain HIV treatment medications:)Tj
/TT1 1 Tf
( didanosine \(Videx EC\): separate Videx EC )Tj
0 -1.22711 TD
(from tipranavir by at least 2 hours)Tj
/TT0 1 Tf
0 -1.2 TD
(Disulfiram/metronidazole:)Tj
/TT1 1 Tf
( tipranavir contains alcohol that can produce a )Tj
0 -1.22711 TD
(reaction with disulfiram or metronidazole)Tj
/TT0 1 Tf
0 -1.2 TD
(Drugs to prevent seizures:)Tj
/TT1 1 Tf
( phenytoin \(Dilantin\))Tj
/TT0 1 Tf
0 -1.2271 TD
(All erectile dysfunction drugs: )Tj
/TT1 1 Tf
(sildenafil \(Viagra\), tadalafil \(Cialis\), vardenafil )Tj
0 -1.22711 TD
(\(Levitra\) )Tj
/TT0 1 Tf
0 -1.1729 TD
(Drugs to prevent rejection of transplanted organs or bone marrow: )Tj
/TT1 1 Tf
0 -1.22711 TD
(cyclosporine \(Neoral, Sandimmune\), tacrolimus \(FK506, Prograf\), siro\
limus )Tj
0 -1.2 TD
(\(Rapamune\))Tj
/TT0 1 Tf
T*
(Drugs to treat mycobacteria or TB-like infections: )Tj
/TT1 1 Tf
(Rifabutin \(Mycobutin\) )Tj
0 -1.2271 TD
([decrease rifabutin to 150 mg every other day])Tj
/TT0 1 Tf
0 -1.2 TD
(Pain medication)Tj
/TT1 1 Tf
(: methadone \(Dolophine, Methadose\), meperidine \(Demerol\) )Tj
0 -1.22711 TD
([avoid higher dosages and long-term use])Tj
/TT0 1 Tf
0 -1.2 TD
(Oral contraceptive pills)Tj
/TT1 1 Tf
( \(another form of contraception should be used in )Tj
0 -1.22711 TD
(addition\). Also there is an increased chance of skin rash if someone t\
akes )Tj
0 -1.2 TD
(ethinyl estradiol with tipranavir.)Tj
/TT0 1 Tf
T*
(Statin drugs:)Tj
/TT1 1 Tf
( atorvastatin \(Lipitor\) [start with lowest possible dose])Tj
/TT0 1 Tf
0 -1.2271 TD
(Certain antibiotics:)Tj
/TT1 1 Tf
( clarithromycin \(Biaxin\) [reduce dose of Biaxin if your kidney )Tj
0 -1.22711 TD
(function is less than 1/3 of normal])Tj
/TT0 1 Tf
0 -1.2 TD
(Antifungals:)Tj
/TT1 1 Tf
( ketoconazole \(Nizoral\), itraconazole \(Sporanox\), voriconazole )Tj
0 -1.22711 TD
(\(Vfend\))Tj
/TT0 1 Tf
0 -1.2 TD
(Blood thinning medications:)Tj
/TT1 1 Tf
( warfarin \(Coumadin\))Tj
1 0 0 rg
/TT0 1 Tf
15 0 0 15 22 136.93054 Tm
(Report to you healthcare provider or go to an Emergency Room)Tj
/TT1 1 Tf
( )Tj
0 0 0 rg
12.5 0 0 12.5 480.42999 136.93054 Tm
(if you have severe )Tj
-36.67439 -1.30136 Td
(side effects, skin rash, increasing side effects, shortness of breath, u\
ncontrollable diarrhea, back pain, )Tj
T*
(groin pain, fever, weakness, jaundice \(eyes and skin turn yellow,\) mus\
cle pain, nausea and vomiting )Tj
T*
(so that you cannot hold down your food and liquids.)Tj
12.92308 0 0 12.92308 22 61.30142 Tm
(You can download this handout in PDF format by clicking )Tj
0.50197 0 0.50197 rg
/TT0 1 Tf
(HERE)Tj
0 0 0 rg
/TT1 1 Tf
(.)Tj
ET
EMC
/Artifact <>BDC
Q
0 0 0 rg
BT
/T1_0 1 Tf
9 0 0 9 18 7.17 Tm
(http://www.hivinfo.us/tipranavir.html \(3 of 4\)7/24/2005 7:55:46 AM)Tj
ET
EMC
endstream
endobj
44 0 obj 516
endobj
45 0 obj<>stream
/Artifact <>BDC
0 0 0 rg
0 i
BT
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 18 780.17 Tm
(HIVInfo.us - Aptivus - tipranavir information)Tj
ET
EMC
/Article <>BDC
q
0 18 612 756 re
W* n
BT
/TT0 1 Tf
10 0 0 10 10 744.94505 Tm
(7.24.2005)Tj
ET
EMC
/Artifact <>BDC
Q
BT
/T1_0 1 Tf
9 0 0 9 18 7.17 Tm
(http://www.hivinfo.us/tipranavir.html \(4 of 4\)7/24/2005 7:55:46 AM)Tj
ET
EMC
endstream
endobj
46 0 obj(HIVInfo.us - Aptivus - tipranavir information)
endobj
47 0 obj<>
endobj
48 0 obj<>
endobj
49 0 obj<>
endobj
50 0 obj<>
endobj
51 0 obj[48 0 R]
endobj
52 0 obj(http://www.hivinfo.us/tipranavir.html)
endobj
53 0 obj(Sg+}u,0)
endobj
54 0 obj<>
endobj
55 0 obj<>
endobj
56 0 obj(KvSB)
endobj
57 0 obj<>
endobj
58 0 obj<>
endobj
59 0 obj<>
endobj
60 0 obj<>
endobj
61 0 obj<>
endobj
62 0 obj<>stream
HIVInfo.us - Aptivus - tipranavir information
endstream
endobj
xref
0 63
0000000004 65535 f
0000000016 00000 n
0000000159 00000 n
0000000231 00000 n
0000000000 00001 f
0000000402 00000 n
0000000422 00000 n
0000000488 00000 n
0000000588 00000 n
0000000632 00000 n
0000000679 00000 n
0000000892 00000 n
0000001108 00000 n
0000001275 00000 n
0000001399 00000 n
0000001475 00000 n
0000001564 00000 n
0000002755 00000 n
0000002800 00000 n
0000002862 00000 n
0000002886 00000 n
0000003059 00000 n
0000003228 00000 n
0000003397 00000 n
0000003588 00000 n
0000003619 00000 n
0000003824 00000 n
0000003855 00000 n
0000004031 00000 n
0000004055 00000 n
0000004235 00000 n
0000004259 00000 n
0000004349 00000 n
0000005526 00000 n
0000005700 00000 n
0000006873 00000 n
0000007041 00000 n
0000008221 00000 n
0000008396 00000 n
0000008417 00000 n
0000017806 00000 n
0000017827 00000 n
0000024192 00000 n
0000024213 00000 n
0000030472 00000 n
0000030492 00000 n
0000031061 00000 n
0000031124 00000 n
0000031160 00000 n
0000031232 00000 n
0000031261 00000 n
0000031370 00000 n
0000031394 00000 n
0000031449 00000 n
0000031483 00000 n
0000031615 00000 n
0000031666 00000 n
0000031700 00000 n
0000031743 00000 n
0000031784 00000 n
0000031825 00000 n
0000031913 00000 n
0000032038 00000 n
trailer
<]>>
startxref
35382
%%EOF
1 0 obj<>
endobj
2 0 obj<>
endobj
3 0 obj<>
endobj
10 0 obj<><><><>]/C/SpdrArt/P 9 0 R/S/Article/Pg 11 0 R>>
endobj
18 0 obj<>
endobj
30 0 obj[null]
endobj
54 0 obj<>
endobj
63 0 obj null
endobj
64 0 obj<>stream
HIVInfo.us - Aptivus - tipranavir information
endstream
endobj
xref
1 3
0000036797 00000 n
0000036940 00000 n
0000037005 00000 n
10 1
0000037176 00000 n
18 1
0000037359 00000 n
29 2
0000000000 00001 f
0000037412 00000 n
54 1
0000037434 00000 n
63 2
0000037559 00000 n
0000037580 00000 n
trailer
<]/Prev 35382 >>
startxref
40924
%%EOF